Research on the Virgo Cluster dwarf galaxy IC4318 led by Yale astrophysicist Dr. Jeffery Kenney reveals several important processes in galaxy evolution.
Yale researchers’ recent study published in PLOS Pathogens will help us treat Dengue fever, a growing international public health issue.
Idiopathic Pulmonary Fibrosis is one of mankind’s deadliest and most mysterious lung diseases. A new study led by Yale School of Medicine, however, is beginning to shed light on IPF’s previously uncharted territory.
James Rothman ’71, Professor of Cell Biology at Yale, has been awarded the Nobel Prize in Physiology or Medicine.
Yale has established the Michele Dufault Endowment fund to support women’s participation in the science, in honor of the Yale Physics and Astronomy senior who passed away in 2011.
“A small molecule found in bacteria and plants is capable of causing major changes in gene expression in response to environmental conditions. Researchers in the Steitz Lab at Yale have solved a long-standing puzzle by figuring out how it works.”
After decades of research, scientists describe biological clocks molecularly independent of the classical circadian clock.
The origins of insects, spiders, scorpions, crustaceans, and their relatives date to more than 500 million years ago, a period termed the Cambrian Explosion, when most of the modern groups of arthropods first occurred. A new study shows that rates of arthropod evolution during this period were 4 to 5 times faster than they are today.
Novel technique uses computers, rather than scalpels, to identify specific genes related to kidney disease.
A team consisting of researchers from the Massachusetts Institute of Technology (MIT) and the National Aeronautics and Space Administration (NASA) is working to develop a
Adam Marcus, Daniel Spielman, and Nikhil Srivastava have proven the 54-year-old mathematical problem known as the Kadison-Singer Conjecture, which holds important consequences for the field of interlacing families as well as the mathematical foundations of quantum physics.
In a collaborative study, researchers from several Yale departments have developed small synthetic molecules that limit damage to the heart from ischemia, which could potentially be developed into drugs to be used in a surgical or therapeutic setting.